elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38184645-45F5D0D3-5B88-46BC-AB39-2FCCEE9A27E2
Q38184645-45F5D0D3-5B88-46BC-AB39-2FCCEE9A27E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38184645-45F5D0D3-5B88-46BC-AB39-2FCCEE9A27E2
Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders.
P2860
Q38184645-45F5D0D3-5B88-46BC-AB39-2FCCEE9A27E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38184645-45F5D0D3-5B88-46BC-AB39-2FCCEE9A27E2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
075c6256fabd3a0765b09b033625f01089fa641e
P2860
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation.